Fast Five Quiz: COVID-Related Conditions

Michael Stuart Bronze, MD; Vecihi Batuman, MD; Arlen D. Meyers, MD, MBA; Stephen Soreff, MD; Helmi L Lutsep, MD


March 16, 2021

According to guidelines on managing the long-term effects of COVID-19 issued by NICE in December 2020, ongoing symptomatic COVID-19 should be suspected in individuals who present with symptoms 4-12 weeks after the start of acute infection. If the symptoms have not resolved 12 weeks or longer after the start of acute infection, PASC is a possible underlying cause. Patients with new or ongoing symptoms 4 weeks or longer after the start of suspected or confirmed COVID-19 should be offered blood tests, including a full blood count as well as kidney and liver function, C-reactive protein, ferritin, B-type natriuretic peptide, and thyroid function tests.

The NICE guidelines also recommend against predicting whether a person is likely to develop PASC based on whether they had certain symptoms (or clusters of symptoms) or were hospitalized with acute COVID-19. The guidelines further state that it is not known whether over-the-counter vitamins and supplements are helpful, harmful, or have no effect in the treatment of new or ongoing symptoms of COVID-19.

Read more about PASC.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.